Abstract
Obesity is associated with low-grade inflammation. Leptin, a hormone made by fat cells regulates appetite and hunger and thus food intake behavior. Interestingly, , food preservatives like sodium sulfite and sodium benzoate and also natural colorant and spice compounds such as curcumin were found to decrease the release of leptin in murine 3T3-L1 adipocytes, after co-incubation with LPS, which was added to mimic the pro-inflammatory status in obesity. Several of these compounds are well known food antioxidants.
Whilst reducing oxidation events is beneficial in states of elevated oxidative stress, overexposure to food antioxidant can lead to adverse effects. There are hints from in vivo data, that antioxidant stress in younger age plays a role in the development of adiposity in later life. The insufficient exposure to oxidizing compounds like reactive oxygen species (ROS) cannot only cause an insufficient burning of calories but there is also a link to the regulation of food intake behavior. If the in vitro findings can be extrapolated to the in vivo situation, consumption of antioxidant supplemented food could lead to decreased leptin release and contribute to an obesogenic environment. This aspect sheds some new critical light on the potential role of an antioxidant-enriched nutrition in the obesity epidemic during the past few centuries. Doing sports could represent not only a proper strategy to initiate physiological ROS production and burning of calories, but also may shift the hormone milieu towards a reduction of hunger feelings and thus reduce appetite and food intake.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abhilash, M. 2010. Potential applications of Nanoparticles. International Journal of Pharma and Bio Sciences 1: 12.
Ait-Oufella, H., S. Taleb, Z. Mallat, and A. Tedgui. 2009. Cytokine network and T cell immunity in atherosclerosis. Seminars in Immunopathology 31: 23–33.
Alvaro, J.D., J.B. Tatro, and R.S. Duman. 1997. Melanocortins and opiate addiction. Life Sciences 61: 1–9.
Anubhuti, and S. Arora. 2008. Leptin and its metabolic interactions: An update. Diabetes, Obesity & Metabolism 10: 973–993.
Arnold, T., S. Brandlhofer, K. Vrtikapa, H. Stangl, M. Hermann, K. Zwiauer, H. Mangge, A. Karwautz, J. Huemer, D. Koller, W.J. Schneider, and W. Strobl. 2011. Effect of obesity on plasma clusterin, [corrected] a proposed modulator of leptin action. Pediatric Research 69: 237–242.
Bahadoran, Z., M. Golzarand, P. Mirmiran, N. Shiva, and F. Azizi. 2012. Dietary total antioxidant capacity and the occurrence of metabolic syndrome and its components after a 3-year follow-up in adults: Tehran lipid and glucose study. Nutrition & Metabolism (London) 9: 70.
Banks, W.A., A.J. Kastin, W. Huang, J.B. Jaspan, and L.M. Maness. 1996. Leptin enters the brain by a saturable system independent of insulin. Peptides 17: 305–311.
Bates, S.H., and M.G. Myers Jr. 2003. The role of leptin receptor signaling in feeding and neuroendocrine function. Trends in Endocrinology and Metabolism 14: 447–452.
Ben Ounis, O., M. Elloumi, G. Lac, E. Makni, E. Van Praagh, H. Zouhal, Z. Tabka, and M. Amri. 2009. Two-month effects of individualized exercise training with or without caloric restriction on plasma adipocytokine levels in obese female adolescents. Annales d'Endocrinologie 70: 235–241.
Benoit, S.C., D.J. Clegg, R.J. Seeley, and S.C. Woods. 2004. Insulin and leptin as adiposity signals. Recent Progress in Hormone Research 59: 267–285.
Benwell, M.E., D.J. Balfour, and J.M. Anderson. 1988. Evidence that tobacco smoking increases the density of (−)-[3H]nicotine binding sites in human brain. Journal of Neurochemistry 50: 1243–1247.
Bjelakovic, G., and C. Gluud. 2007. Surviving antioxidant supplements. Journal of the National Cancer Institute 99: 742–743.
Bjelakovic, G., D. Nikolova, R. G. Simonetti, and C. Gluud 2004a. Antioxidant supplements for preventing gastrointestinal cancers. Cochrane Database of Systematic Reviews 18(4): CD004183.
Bjelakovic, G., D. Nikolova, R.G. Simonetti, and C. Gluud. 2004b. Antioxidant supplements for prevention of gastrointestinal cancers: A systematic review and meta-analysis. Lancet 364: 1219–1228.
Bjelakovic, G., D. Nikolova, L.L. Gluud, R.G. Simonetti, and C. Gluud. 2007. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: Systematic review and meta-analysis. JAMA 297: 842–857.
Bjorbaek, C., R.M. Buchholz, S.M. Davis, S.H. Bates, D.D. Pierroz, H. Gu, B.G. Neel, M.G. Myers Jr., and J.S. Flier. 2001. Divergent roles of SHP-2 in ERK activation by leptin receptors. The Journal of Biological Chemistry 276: 4747–4755.
Bjorbak, C., H.J. Lavery, S.H. Bates, R.K. Olson, S.M. Davis, J.S. Flier, and M.G. Myers Jr. 2000. SOCS3 mediates feedback inhibition of the leptin receptor via Tyr985. The Journal of Biological Chemistry 275: 40649–40657.
Blundell, J.E., and C.L. Lawton. 1995. Serotonin and dietary fat intake: Effects of dexfenfluramine. Metabolism 44: 33–37.
Brandacher, G., C. Winkler, F. Aigner, H. Schwelberger, K. Schroecksnadel, R. Margreiter, D. Fuchs, and H.G. Weiss. 2006. Bariatric surgery cannot prevent tryptophan depletion due to chronic immune activation in morbidly obese patients. Obesity Surgery 16: 541–548.
Brandacher, G., E. Hoeller, D. Fuchs, and H.G. Weiss. 2007. Chronic immune activation underlies morbid obesity: Is IDO a key player? Current Drug Metabolism 8: 289–295.
Bray, G.A. 2001. Drug treatment of obesity. Reviews in Endocrine & Metabolic Disorders 2: 403–418.
Brown, P.M., D.J. Kennedy, R.E. Morton, and M. Febbraio. 2015. CD36/SR-B2-TLR2 dependent pathways enhance porphyromonas gingivalis mediated atherosclerosis in the Ldlr KO mouse model. PLoS One 10: e0125126.
Burtscher, M., D. Pesta, D. Fuchs, M. Ledochowski, and H. Gatterer. 2015. Methodological considerations when evaluating the effectiveness of dietary/supplemental antioxidants in sport. In Antioxidants in Sport Nutrition, ed. M. Lamprecht. Boca Raton, FL: CRC Press. Chapter 13.
Buwalda, B., W.A. Blom, J.M. Koolhaas, and G. Van Dijk. 2001. Behavioral and physiological responses to stress are affected by high-fat feeding in male rats. Physiology & Behavior 73: 371–377.
Califf, R.M. 2009. Key issues for global cardiovascular medicine. Lancet 374: 508–510.
Caraballoso, M., M. Sacristan, C. Serra, and X. Bonfill. 2003. Drugs for preventing lung cancer in healthy people. Cochrane Database of Systematic Reviews 10: CD002141.
Caro, J.F., J.W. Kolaczynski, M.R. Nyce, J.P. Ohannesian, I. Opentanova, W.H. Goldman, R.B. Lynn, P.L. Zhang, M.K. Sinha, and R.V. Considine. 1996. Decreased cerebrospinal-fluid/serum leptin ratio in obesity: A possible mechanism for leptin resistance. Lancet 348: 159–161.
Cascio, G., G. Schiera, and I. Di Liegro. 2012. Dietary fatty acids in metabolic syndrome, diabetes and cardiovascular diseases. Current Diabetes Reviews 8: 2–17.
Ciardi, C., M. Jenny, A. Tschoner, F. Ueberall, J. Patsch, M. Pedrini, C. Ebenbichler, and D. Fuchs. 2012. Food additives such as sodium sulphite, sodium benzoate and curcumin inhibit leptin release in lipopolysaccharide-treated murine adipocytes in vitro. The British Journal of Nutrition 107: 826–833.
Cizza, G., M. Requena, G. Galli, and L. De Jonge. 2011. Chronic sleep deprivation and seasonality: Implications for the obesity epidemic. Journal of Endocrinological Investigation 34: 793–800.
Considine, R.V., M.K. Sinha, M.L. Heiman, A. Kriauciunas, T.W. Stephens, M.R. Nyce, J.P. Ohannesian, C.C. Marco, L.J. Mckee, T.L. Bauer, et al. 1996. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. The New England Journal of Medicine 334: 292–295.
Cottam, D.R., S.G. Mattar, E. Barinas-Mitchell, G. Eid, L. Kuller, D.E. Kelley, and P.R. Schauer. 2004. The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: Implications and effects of weight loss. Obesity Surgery 14: 589–600.
Dandona, P., A. Aljada, A. Chaudhuri, P. Mohanty, and R. Garg. 2005. Metabolic syndrome: A comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 111: 1448–1454.
Davis, J.F., A.L. Tracy, J.D. Schurdak, M.H. Tschop, J.W. Lipton, D.J. Clegg, and S.C. Benoit. 2008. Exposure to elevated levels of dietary fat attenuates psychostimulant reward and mesolimbic dopamine turnover in the rat. Behavioral Neuroscience 122: 1257–1263.
Drogan, D., H. Boeing, J. Janke, B. Schmitt, Y. Zhou, J. Walter, T. Pischon, and S. Tierling. 2015. Regional distribution of body fat in relation to DNA methylation within the LPL, ADIPOQ and PPARgamma promoters in subcutaneous adipose tissue. Nutrition & Diabetes 5: e168.
Eichenbaum, H. 2006. Remembering: Functional organization of the declarative memory system. Current Biology 16: R643–R645.
Estabrooke, I.V., M.T. Mccarthy, E. Ko, T.C. Chou, R.M. Chemelli, M. Yanagisawa, C.B. Saper, and T.E. Scammell. 2001. Fos expression in orexin neurons varies with behavioral state. The Journal of Neuroscience 21: 1656–1662.
Fadel, J., and A.Y. Deutch. 2002. Anatomical substrates of orexin-dopamine interactions: Lateral hypothalamic projections to the ventral tegmental area. Neuroscience 111: 379–387.
Ferry, G., C. Ubeaud, P.H. Lambert, S. Bertin, F. Coge, P. Chomarat, P. Delagrange, B. Serkiz, J.P. Bouchet, R.J. Truscott, and J.A. Boutin. 2005. Molecular evidence that melatonin is enzymatically oxidized in a different manner than tryptophan: Investigations with both indoleamine 2,3-dioxygenase and myeloperoxidase. Biochemical Journal 388: 205–215.
Figlewicz, D.P., S.B. Evans, J. Murphy, M. Hoen, and D.G. Baskin. 2003. Expression of receptors for insulin and leptin in the ventral tegmental area/substantia nigra (VTA/SN) of the rat. Brain Research 964: 107–115.
Figlewicz, D.P., J.L. Bennett, S. Aliakbari, A. Zavosh, and A.J. Sipols. 2008. Insulin acts at different CNS sites to decrease acute sucrose intake and sucrose self-administration in rats. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 295: R388–R394.
Flaherman, V., and G.W. Rutherford. 2006. A meta-analysis of the effect of high weight on asthma. Archives of Disease in Childhood 91: 334–339.
Flier, J.S. 2012. Hormone resistance in diabetes and obesity: Insulin, leptin, and FGF21. The Yale Journal of Biology and Medicine 85: 405–414.
Fuchs, D. 2012. Antioxidant intake and allergic disease. Clinical and Experimental Allergy 42: 1420–1422.
Gleeson, M., N.C. Bishop, D.J. Stensel, M.R. Lindley, S.S. Mastana, and M.A. Nimmo. 2011. The anti-inflammatory effects of exercise: Mechanisms and implications for the prevention and treatment of disease. Nature Reviews. Immunology 11: 607–615.
Gleissenthall, G.V., S. Geisler, P. Malik, G. Kemmler, H. Benicke, D. Fuchs, and S. Mechtcheriakov. 2014. Tryptophan metabolism in post-withdrawal alcohol-dependent patients. Alcohol and Alcoholism 49: 251–255.
Gostner, J.M., K. Becker, K.D. Croft, R.J. Woodman, I.B. Puddey, D. Fuchs, and J.M. Hodgson. 2014. Regular consumption of black tea increases circulating kynurenine concentrations: A randomized controlled trial. BBA Clinical 3: 31–35.
Hagan, M.M., F.D. Holguin, C.E. Cabello, D.R. Hanscom, and D.E. Moss. 1997. Combined naloxone and fluoxetine on deprivation-induced binge eating of palatable foods in rats. Pharmacology, Biochemistry, and Behavior 58: 1103–1107.
Halford, J.C., and J.E. Blundell. 2000. Separate systems for serotonin and leptin in appetite control. Annals of Medicine 32: 222–232.
Hamilton, B.S., D. Paglia, A.Y. Kwan, and M. Deitel. 1995. Increased obese mRNA expression in omental fat cells from massively obese humans. Nature Medicine 1: 953–956.
Haroon, E., C.L. Raison, and A.H. Miller. 2012. Psychoneuroimmunology meets neuropsychopharmacology: Translational implications of the impact of inflammation on behavior. Neuropsychopharmacology 37: 137–162.
Heymsfield, S.B., A.S. Greenberg, K. Fujioka, R.M. Dixon, R. Kushner, T. Hunt, J.A. Lubina, J. Patane, B. Self, P. Hunt, and M. Mccamish. 1999. Recombinant leptin for weight loss in obese and lean adults: A randomized, controlled, dose-escalation trial. JAMA 282: 1568–1575.
Jequier, E. 2002. Leptin signaling, adiposity, and energy balance. Annals of the New York Academy of Sciences 967: 379–388.
Jimenez-Pavon, D., F.B. Ortega, E.G. Artero, I. Labayen, G. Vicente-Rodriguez, I. Huybrechts, L.A. Moreno, Y. Manios, L. Beghin, A. Polito, S. De Henauw, M. Sjostrom, M.J. Castillo, M. Gonzalez-Gross, J.R. Ruiz, and HELENA Study Group. 2012. Physical activity, fitness, and serum leptin concentrations in adolescents. The Journal of Pediatrics 160(598-603): e2.
Karasz, A.B., J.J. Maxstadt, J. Reher, and F. Decocco. 1976. Rapid screening procedure for the determination of preservatives in ground beef: Sulfites, benzoates, sorbates, and ascorbates. Journal of the Association of Official Analytical Chemists 59: 766–769.
Kenny, P.J. 2011. Reward mechanisms in obesity: New insights and future directions. Neuron 69: 664–679.
Kim, K.S., Y.R. Yoon, H.J. Lee, S. Yoon, S.Y. Kim, S.W. Shin, J.J. An, M.S. Kim, S.Y. Choi, W. Sun, and J.H. Baik. 2010. Enhanced hypothalamic leptin signaling in mice lacking dopamine D2 receptors. The Journal of Biological Chemistry 285: 8905–8917.
Kitagawa, A., Y. Ohta, and K. Ohashi. 2012. Melatonin improves metabolic syndrome induced by high fructose intake in rats. Journal of Pineal Research 52: 403–413.
Lago, R., R. Gomez, F. Lago, J. Gomez-Reino, and O. Gualillo. 2008. Leptin beyond body weight regulation—current concepts concerning its role in immune function and inflammation. Cellular Immunology 252: 139–145.
Leshan, R.L., D.M. Opland, G.W. Louis, G.M. Leinninger, C.M. Patterson, C.J. Rhodes, H. Munzberg, and M.G. Myers Jr. 2010. Ventral tegmental area leptin receptor neurons specifically project to and regulate cocaine- and amphetamine-regulated transcript neurons of the extended central amygdala. The Journal of Neuroscience 30: 5713–5723.
Liang, S., M. Aiqun, L. Jiwu, and Z. Ping. 2015. TLR3 and TLR4 as potential clinical biomarkers for in-stent restenosis in drug-eluting stents patients. Immunologic Research 64(2): 424–430.
Lu, Z., X. Zhang, Y. Li, M.F. Lopes-Virella, and Y. Huang. 2015. TLR4 antagonist attenuates atherogenesis in LDL receptor-deficient mice with diet-induced type 2 diabetes. Immunobiology 220(11): 1246–1254.
Lucey, D.R., M. Clerici, and G.M. Shearer. 1996. Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases. Clinical Microbiology Reviews 9: 532–562.
Luck, E. 1990. Food applications of sorbic acid and its salts. Food Additives and Contaminants 7: 711–715.
Maffei, M., J. Halaas, E. Ravussin, R.E. Pratley, G.H. Lee, Y. Zhang, H. Fei, S. Kim, R. Lallone, S. Ranganathan, et al. 1995. Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nature Medicine 1: 1155–1161.
Mangge, H., K. Schauenstein, L. Stroedter, A. Griesl, W. Maerz, and M. Borkenstein. 2004. Low grade inflammation in juvenile obesity and type 1 diabetes associated with early signs of atherosclerosis. Experimental and Clinical Endocrinology & Diabetes 112: 378–382.
Mangge, H., G. Almer, S. Haj-Yahya, S. Pilz, R. Gasser, R. Moller, and R. Horejsi. 2008. Preatherosclerosis and adiponectin subfractions in obese adolescents. Obesity (Silver Spring) 16: 2578–2584.
Mangge, H., G. Almer, M. Truschnig-Wilders, A. Schmidt, R. Gasser, and D. Fuchs. 2010. Inflammation, adiponectin, obesity and cardiovascular risk. Current Medicinal Chemistry 17: 4511–4520.
Mangge, H., K. Summers, G. Almer, R. Prassl, D. Weghuber, W. Schnedl, and D. Fuchs. 2013. Antioxidant food supplements and obesity-related inflammation. Current Medicinal Chemistry 20: 2330–2337.
Mccall, M.R., and B. Frei. 1999. Can antioxidant vitamins materially reduce oxidative damage in humans? Free Radical Biology & Medicine 26: 1034–1053.
Moraes-Vieira, P.M., R.A. Larocca, E.J. Bassi, J.P. Peron, V. Andrade-Oliveira, F. Wasinski, R. Araujo, T. Thornley, F.J. Quintana, A.S. Basso, T.B. Strom, and N.O. Camara. 2014. Leptin deficiency impairs maturation of dendritic cells and enhances induction of regulatory T and Th17 cells. European Journal of Immunology 44: 794–806.
Mrakic-Sposta, S., M. Gussoni, S. Moretti, L. Pratali, G. Giardini, P. Tacchini, C. Dellanoce, A. Tonacci, F. Mastorci, A. Borghini, M. Montorsi, and A. Vezzoli. 2015. Effects of Mountain ultra-marathon running on ROS Production and oxidative damage by micro-invasive analytic techniques. PLoS One 10(11): e0141780.
Murr, C., K. Schroecksnadel, C. Winkler, M. Ledochowski, and D. Fuchs. 2005. Antioxidants may increase the probability of developing allergic diseases and asthma. Medical Hypotheses 64: 973–977.
Nakamura, A., K. Kawakami, F. Kametani, H. Nakamoto, and S. Goto. 2010. Biological significance of protein modifications in aging and calorie restriction. Annals of the New York Academy of Sciences 1197: 33–39.
Nduhirabandi, F., E.F. Du Toit, and A. Lochner. 2012. Melatonin and the metabolic syndrome: A tool for effective therapy in obesity-associated abnormalities? Acta Physiologica (Oxford, England) 205: 209–223.
Netzer, N., H. Gatterer, M. Faulhaber, M. Burtscher, S. Pramsohler, and D. Pesta. 2015. Hypoxia, oxidative stress and fat. Biomolecules 5: 1143–1150.
Neurauter, G., K. Schrocksnadel, S. Scholl-Burgi, B. Sperner-Unterweger, C. Schubert, M. Ledochowski, and D. Fuchs. 2008. Chronic immune stimulation correlates with reduced phenylalanine turnover. Current Drug Metabolism 9: 622–627.
Opland, D.M., G.M. Leinninger, and M.G. Myers Jr. 2010. Modulation of the mesolimbic dopamine system by leptin. Brain Research 1350: 65–70.
Pacifico, L., L. Di Renzo, C. Anania, J.F. Osborn, F. Ippoliti, E. Schiavo, and C. Chiesa. 2006. Increased T-helper interferon-gamma-secreting cells in obese children. European Journal of Endocrinology 154: 691–697.
Palovcik, R.A., M.I. Phillips, M.S. Kappy, and M.K. Raizada. 1984. Insulin inhibits pyramidal neurons in hippocampal slices. Brain Research 309: 187–191.
Peruzzo, B., F.E. Pastor, J.L. Blazquez, K. Schobitz, B. Pelaez, P. Amat, and E.M. Rodriguez. 2000. A second look at the barriers of the medial basal hypothalamus. Experimental Brain Research 132: 10–26.
Peschke, E. 2008. Melatonin, endocrine pancreas and diabetes. Journal of Pineal Research 44: 26–40.
Peternelj, T.T., and J.S. Coombes. 2011. Antioxidant supplementation during exercise training: beneficial or detrimental? Sports Medicine 41(12): 1043–1069.
Picinato, M.C., E.P. Haber, J. Cipolla-Neto, R. Curi, C.R. De Oliveira Carvalho, and A.R. Carpinelli. 2002. Melatonin inhibits insulin secretion and decreases PKA levels without interfering with glucose metabolism in rat pancreatic islets. Journal of Pineal Research 33: 156–160.
Pilz, S., R. Horejsi, R. Moller, G. Almer, H. Scharnagl, T. Stojakovic, R. Dimitrova, G. Weihrauch, M. Borkenstein, W. Maerz, K. Schauenstein, and H. Mangge. 2005. Early atherosclerosis in obese juveniles is associated with low serum levels of adiponectin. The Journal of Clinical Endocrinology and Metabolism 90: 4792–4796.
Poljsak, B., and I. Milisav. 2012. The neglected significance of “antioxidative stress”. Oxidative Medicine and Cellular Longevity 2012: 480895.
Powers, S.K., and M.J. Jackson. 2008. Exercise-induced oxidative stress: Cellular mechanisms and impact on muscle force production. Physiological Reviews 88: 1243–1276.
Ramos, E.J., M.M. Meguid, A.C. Campos, and J.C. Coelho. 2005. Neuropeptide Y, alpha-melanocyte-stimulating hormone, and monoamines in food intake regulation. Nutrition 21: 269–279.
Rasmussen, D.D., B.M. Boldt, C.W. Wilkinson, S.M. Yellon, and A.M. Matsumoto. 1999. Daily melatonin administration at middle age suppresses male rat visceral fat, plasma leptin, and plasma insulin to youthful levels. Endocrinology 140: 1009–1012.
Riccardi, G., R. Giacco, and A.A. Rivellese. 2004. Dietary fat, insulin sensitivity and the metabolic syndrome. Clinical Nutrition 23: 447–456.
Ristow, M., K. Zarse, A. Oberbach, N. Kloting, M. Birringer, M. Kiehntopf, M. Stumvoll, C.R. Kahn, and M. Bluher. 2009. Antioxidants prevent health-promoting effects of physical exercise in humans. Proceedings of the National Academy of Sciences of the United States of America 106: 8665–8670.
Rocha, V.Z., E.J. Folco, G. Sukhova, K. Shimizu, I. Gotsman, A.H. Vernon, and P. Libby. 2008. Interferon-gamma, a Th1 cytokine, regulates fat inflammation: A role for adaptive immunity in obesity. Circulation Research 103: 467–476.
Romagnani, S. 2004. Immunologic influences on allergy and the TH1/TH2 balance. The Journal of Allergy and Clinical Immunology 113: 395–400.
Saladin, R., P. De Vos, M. Guerre-Millo, A. Leturque, J. Girard, B. Staels, and J. Auwerx. 1995. Transient increase in obese gene expression after food intake or insulin administration. Nature 377: 527–529.
Salagianni, M., I.E. Galani, A.M. Lundberg, C.H. Davos, A. Varela, A. Gavriil, L.P. Lyytikainen, T. Lehtimaki, F. Sigala, L. Folkersen, V. Gorgoulis, S. Lenglet, F. Montecucco, F. Mach, U. Hedin, G.K. Hansson, C. Monaco, and E. Andreakos. 2012. Toll-like receptor 7 protects from atherosclerosis by constraining “inflammatory” macrophage activation. Circulation 126: 952–962.
Scarpace, P.J., and Y. Zhang. 2009. Leptin resistance: A prediposing factor for diet-induced obesity. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 296: R493–R500.
Schroecksnadel, K., B. Fischer, H. Schennach, G. Weiss, and D. Fuchs. 2007. Antioxidants suppress Th1-type immune response in vitro. Drug Metabolism Letters 1: 166–171.
Schwartz, M.W., E. Peskind, M. Raskind, E.J. Boyko, and D. Porte Jr. 1996. Cerebrospinal fluid leptin levels: Relationship to plasma levels and to adiposity in humans. Nature Medicine 2: 589–593.
Sies, H. 2014. Role of metabolic H2O2 generation: Redox signaling and oxidative stress. The Journal of Biological Chemistry 289: 8735–8741.
Smith, G.P. 2000. The controls of eating: A shift from nutritional homeostasis to behavioral neuroscience. Nutrition 16: 814–820.
Squire, L.R. 2004. Memory systems of the brain: A brief history and current perspective. Neurobiology of Learning and Memory 82: 171–177.
Stelzer, I., S. Zelzer, R.B. Raggam, F. Pruller, M. Truschnig-Wilders, A. Meinitzer, W.J. Schnedl, R. Horejsi, R. Moller, D. Weghuber, G. Reeves, T.T. Postolache, and H. Mangge. 2012. Link between leptin and interleukin-6 levels in the initial phase of obesity related inflammation. Translational Research 159: 118–124.
Stice, E., S. Spoor, C. Bohon, M.G. Veldhuizen, and D.M. Small. 2008. Relation of reward from food intake and anticipated food intake to obesity: A functional magnetic resonance imaging study. Journal of Abnormal Psychology 117: 924–935.
Tan, P.H., P. Sagoo, C. Chan, J.B. Yates, J. Campbell, S.C. Beutelspacher, B.M. Foxwell, G. Lombardi, and A.J. George. 2005. Inhibition of NF-kappa B and oxidative pathways in human dendritic cells by antioxidative vitamins generates regulatory T cells. Journal of Immunology 174: 7633–7644.
Tan, D.X., L.C. Manchester, L. Fuentes-Broto, S.D. Paredes, and R.J. Reiter. 2011. Significance and application of melatonin in the regulation of brown adipose tissue metabolism: Relation to human obesity. Obesity Reviews 12: 167–188.
Vaisse, C., J.L. Halaas, C.M. Horvath, J.E. Darnell Jr., M. Stoffel, and J.M. Friedman. 1996. Leptin activation of Stat3 in the hypothalamus of wild-type and ob/ob mice but not db/db mice. Nature Genetics 14: 95–97.
Van Cauter, E., and K.L. Knutson. 2008. Sleep and the epidemic of obesity in children and adults. European Journal of Endocrinology 159(Suppl 1): S59–S66.
Violi, F., L. Loffredo, L. Musella, and A. Marcoccia. 2004. Should antioxidant status be considered in interventional trials with antioxidants? Heart 90: 598–602.
Vivekananthan, D.P., M.S. Penn, S.K. Sapp, A. Hsu, and E.J. Topol. 2003. Use of antioxidant vitamins for the prevention of cardiovascular disease: Meta-analysis of randomised trials. Lancet 361: 2017–2023.
Volkow, N.D., G.J. Wang, J.S. Fowler, D. Tomasi, and R. Baler. 2012a. Food and drug reward: Overlapping circuits in human obesity and addiction. Current Topics in Behavioral Neurosciences 11: 1–24.
Volkow, N.D., G.J. Wang, D. Tomasi, and R.D. Baler. 2012b. Obesity and addiction: Neurobiological overlaps. Obesity Reviews 14(1): 2–18.
Wallner-Liebmann, S., K. Koschutnig, G. Reishofer, E. Sorantin, B. Blaschitz, R. Kruschitz, H.F. Unterrainer, R. Gasser, F. Freytag, C. Bauer-Denk, A. Schienle, A. Schafer, and H. Mangge. 2010. Insulin and hippocampus activation in response to images of high-calorie food in normal weight and obese adolescents. Obesity (Silver Spring) 18: 1552–1557.
Wang, Y., M.A. Beydoun, L. Liang, B. Caballero, and S.K. Kumanyika. 2008. Will all Americans become overweight or obese? estimating the progression and cost of the US obesity epidemic. Obesity (Silver Spring) 16: 2323–2330.
Wellman, P.J., J.R. Nation, and K.W. Davis. 2007. Impairment of acquisition of cocaine self-administration in rats maintained on a high-fat diet. Pharmacology, Biochemistry, and Behavior 88: 89–93.
Winkler, C., B. Frick, K. Schroecksnadel, H. Schennach, and D. Fuchs. 2006. Food preservatives sodium sulfite and sorbic acid suppress mitogen-stimulated peripheral blood mononuclear cells. Food and Chemical Toxicology 44: 2003–2007.
Wirleitner, B., K. Schroecksnadel, C. Winkler, H. Schennach, and D. Fuchs. 2005. Resveratrol suppresses interferon-gamma-induced biochemical pathways in human peripheral blood mononuclear cells in vitro. Immunology Letters 100: 159–163.
Wolden-Hanson, T., D.R. Mitton, R.L. Mccants, S.M. Yellon, C.W. Wilkinson, A.M. Matsumoto, and D.D. Rasmussen. 2000. Daily melatonin administration to middle-aged male rats suppresses body weight, intraabdominal adiposity, and plasma leptin and insulin independent of food intake and total body fat. Endocrinology 141: 487–497.
Wu, M.F., J. John, N. Maidment, H.A. Lam, and J.M. Siegel. 2002. Hypocretin release in normal and narcoleptic dogs after food and sleep deprivation, eating, and movement. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 283: R1079–R1086.
Wurtman, R.J., and J.J. Wurtman. 1995. Brain serotonin, carbohydrate-craving, obesity and depression. Obesity Research 3(Suppl 4): 477S–480S.
Yu, S., X. Guo, H. Yang, L. Zheng, and Y. Sun. 2015. Metabolic syndrome in hypertensive adults from rural Northeast China: An update. BMC Public Health 15: 247.
Zaknun, D., S. Schroecksnadel, K. Kurz, and D. Fuchs. 2012. Potential role of antioxidant food supplements, preservatives and colorants in the pathogenesis of allergy and asthma. International Archives of Allergy and Immunology 157: 113–124.
Zeitzer, J.M., C.L. Buckmaster, D.M. Lyons, and E. Mignot. 2007. Increasing length of wakefulness and modulation of hypocretin-1 in the wake-consolidated squirrel monkey. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 293: R1736–R1742.
Ziauddeen, H., I.S. Farooqi, and P.C. Fletcher. 2012. Obesity and the brain: How convincing is the addiction model? Nature Reviews. Neuroscience 13: 279–286.
Zimmet, P., K.G. Alberti, and J. Shaw. 2001. Global and societal implications of the diabetes epidemic. Nature 414: 782–787.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Mangge, H., Ciardi, C., Becker, K., Strasser, B., Fuchs, D., Gostner, J.M. (2017). Influence of Antioxidants on Leptin Metabolism and its Role in the Pathogenesis of Obesity. In: Engin, A., Engin, A. (eds) Obesity and Lipotoxicity. Advances in Experimental Medicine and Biology, vol 960. Springer, Cham. https://doi.org/10.1007/978-3-319-48382-5_17
Download citation
DOI: https://doi.org/10.1007/978-3-319-48382-5_17
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-48380-1
Online ISBN: 978-3-319-48382-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)